These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Update on the use of intravenous immune globulin in the treatment of patients with inflammatory muscle disease. Dalakas MC J Clin Immunol; 1995 Nov; 15(6 Suppl):70S-75S. PubMed ID: 8613495 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of inflammatory myopathies: practical approach and future prospects. Dalakas MC Curr Treat Options Neurol; 2011 Jun; 13(3):311-23. PubMed ID: 21365201 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Dalakas MC Ther Adv Neurol Disord; 2008 Nov; 1(3):157-66. PubMed ID: 21180574 [TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and therapy for polymyositis and dermatomyositis]. Kawai S Nihon Naika Gakkai Zasshi; 2007 Oct; 96(10):2171-6. PubMed ID: 18044152 [No Abstract] [Full Text] [Related]
8. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Dalakas MC Curr Opin Neurol; 2004 Oct; 17(5):561-7. PubMed ID: 15367860 [TBL] [Abstract][Full Text] [Related]
9. [Current therapy for polymyositis and dermatomyositis]. Chérin P Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983 [TBL] [Abstract][Full Text] [Related]
10. Potential therapeutic targets for idiopathic inflammatory myopathies. De Bleecker JL; Creus KK; De Paepe B Drug News Perspect; 2006 Nov; 19(9):549-57. PubMed ID: 17220960 [TBL] [Abstract][Full Text] [Related]
12. Polymyositis and dermatomyositis. Dalakas MC; Hohlfeld R Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932 [TBL] [Abstract][Full Text] [Related]
13. Classification, diagnosis, and management of idiopathic inflammatory myopathies. Lazarou IN; Guerne PA J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386 [TBL] [Abstract][Full Text] [Related]
14. Controlled studies with high-dose intravenous immunoglobulin in the treatment of dermatomyositis, inclusion body myositis, and polymyositis. Dalakas MC Neurology; 1998 Dec; 51(6 Suppl 5):S37-45. PubMed ID: 9851729 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy. Dourmishev LA Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112 [TBL] [Abstract][Full Text] [Related]
16. 64th ENMC International Workshop: therapeutic approaches to dermatomyositis, polymyositis, and inclusion body myositis29-31 January 1999, Naarden, The Netherlands. Müller-Felber W; Pongratz D; Reimers C Neuromuscul Disord; 2001 Jan; 11(1):88-92. PubMed ID: 11166170 [No Abstract] [Full Text] [Related]
17. Therapeutic approaches in patients with inflammatory myopathies. Dalakas MC Semin Neurol; 2003 Jun; 23(2):199-206. PubMed ID: 12894385 [TBL] [Abstract][Full Text] [Related]